TCM
AEON icon

Tenor Capital Management’s AEON Biopharma AEON Stock Holding History

Tenor Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,778
Closed -$1.42M – 391
2023
Q2 		$1.42M Hold
2,778
– – 0.03% 159
2023
Q1 		$2.03M Sell
2,778
-4,163
-60% -$3.02M 0.04% 185
2022
Q4 		$5.02M Hold
6,941
– – 0.12% 130
2022
Q3 		$4.92M Hold
6,941
– – 0.11% 152
2022
Q2 		$4.9M Hold
6,941
– – 0.11% 151
2022
Q1 		$4.89M Hold
6,941
– – 0.1% 151
2021
Q4 		$4.85M Hold
6,941
– – 0.1% 145
2021
Q3 		$4.87M Hold
6,941
– – 0.11% 128
2021
Q2 		$4.82M Buy
+6,941
New +$4.85M 0.1% 122

Other funds holding AEON

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tenor Capital Management's AEON Position: Q3 2023 in Review

Tenor Capital Management sold out of AEON Biopharma (AEON) in Q3 2023, closing a stake of 2,778 shares — an estimated $1.42M sold.

Tenor Capital Management first reported a position in AEON in Q2 2021 and held it in 9 quarters. The position peaked at $5.02M in Q4 2022. 15 funds tracked by Wall St. Rank hold AEON as of Q3 2023.

  • Tenor Capital Management reported no remaining AEON Biopharma position as of Q3 2023 after selling out during the quarter.
  • Tenor Capital Management sold 2,778 AEON Biopharma shares in Q3 2023, an estimated $1.42M.
  • Tenor Capital Management first reported a position in AEON Biopharma in Q2 2021 and held it in 9 quarters.
  • Tenor Capital Management's AEON Biopharma position peaked at $5.02M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2023.

Based on Tenor Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.